Dual Viscosity Mixture Vehicle for Intratympanic Dexamethasone Delivery Can Block Ototoxic Hearing Loss

Clinically there is no effective method to prevent drug induced hearing loss in patients undergoing chemotherapy and anti-tuberculosis therapy. In this study, we developed an intratympanic (IT) local drug delivery vehicle featuring hyaluronic acid-based dual viscosity mixture encapsulation of dexame...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hui, Suh, Myung-Whan, Oh, Seung Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581269/
https://www.ncbi.nlm.nih.gov/pubmed/34776942
http://dx.doi.org/10.3389/fphar.2021.701002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581269/
https://www.ncbi.nlm.nih.gov/pubmed/34776942
http://dx.doi.org/10.3389/fphar.2021.701002

Ejemplares similares